News
2h
HealthDay on MSNStapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the ...
In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...
Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.
The Food and Drug Administration has granted Fast Track designation to CELZ-201-DDT for the treatment of degenerative disc disease.
Antidepressant–placebo response-differences (RDs) in controlled trials have been declining, potentially confounding comparisons among older and newer drugs. For clinically employed ...
Poor oral bacteria may hinder blood pressure benefits, but Exeter study finds beetroot juice’s nitrates restore balance, ...
Among children with eosinophilic asthma receiving mepolizumab who had an exacerbation during an acute respiratory illness, ...
Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results